Annual Report

Overview

The report describes Navana Pharmaceuticals Limited's transformation journey under new ownership and management, with 2021-2022 net sales of 4,758.71 million and net profit of 274.00 million. It reports 2,925 manpower and identifies contribution to multiple Sustainable Development Goals. The report also covers non-financial performance through an integrated-reporting approach for July 2021 to June 2022.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2021-2022
Period: 1 July 2021 – 30 June 2022
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services